BenQ Medical Technology Corporation (4116.TWO)
TWD 46.4
(-0.32%)
TWD 46.4
(-0.32%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 442.34 Million | 378.77 Million | 121.34 Million | 151.48 Million | 169.23 Million |
| Net Income | 114.58 Million | 274.89 Million | 61.78 Million | 105.67 Million | 119.3 Million |
| Depreciation & Amortization | 229.22 Million | 190 Million | 101.04 Million | 85.58 Million | 74.82 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 11.95 Million | 34.1 Million | -23.68 Million | -9.44 Million | -1.1 Million |
| Other non-cash items | 86.59 Million | -69.06 Million | 4.02 Million | 3.21 Million | 2.99 Million |
| Investing Cash Flow | -278.98 Million | -103.99 Million | -98.76 Million | -104.06 Million | -23.25 Million |
| Investments in PPE | -133.46 Million | -60.05 Million | -32.92 Million | -42.36 Million | -21.14 Million |
| Acquisitions | 5.44 Million | 76.24 Million | - | -10.21 Million | - |
| Investment purchases | -128.68 Million | -138 Million | -100 Million | -35.16 Million | - |
| Sales/Maturities of investments | - | 87 Thousand | 37 Million | - | 7.17 Million |
| Other Investing Activities | -145.51 Million | -5.33 Million | -3.28 Million | -16.38 Million | -11.39 Million |
| Financing Cash Flow | -312.56 Million | 2.43 Million | 92.14 Million | -34.99 Million | -220.5 Million |
| Debt repayment | -351.65 Million | -118.47 Million | -196.28 Million | -74 Million | -112.95 Million |
| Dividends payments | -93.58 Million | -22.28 Million | -44.56 Million | -60.16 Million | -60.16 Million |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -498.61 Million | -30.91 Million | -24.48 Million | -17.08 Million | -20.13 Million |
| Accounts receivables | -1.44 Million | -9.55 Million | - | - | - |
| Accounts payables | -26.41 Million | - | - | - | - |
| Inventory | -40.81 Million | -4.71 Million | -7.06 Million | -25.79 Million | -20.26 Million |
| Other working capital | 54.21 Million | 48.36 Million | - | - | - |
| Cash at beginning of period | 979.78 Million | 369.85 Million | 255.05 Million | 242.62 Million | 317.55 Million |
| Cash at end of period | 830.5 Million | 647.26 Million | 369.85 Million | 255.05 Million | 242.62 Million |
| Capital Expenditure | -133.46 Million | -60.05 Million | -32.92 Million | -42.36 Million | -21.14 Million |
| Effect of forex changes on cash | -73 Thousand | 200 Thousand | 68 Thousand | -1000.00 | -407 Thousand |
| Net cash flow / Change in cash | -149.27 Million | 277.41 Million | 114.79 Million | 12.42 Million | -74.92 Million |
| Free Cash Flow | 308.88 Million | 318.71 Million | 88.42 Million | 109.11 Million | 148.08 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 85.84 Million | 82.47 Million | 59.71 Million | 36.96 Million | 156.96 Million | 20.47 Million |
| Depreciation & Amortization | 64.6 Million | 62.3 Million | 60.12 Million | 57.99 Million | 79.19 Million | 35.81 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -24.94 Million | -63.02 Million | -86.94 Million | 65.62 Million | -99.98 Million | 19.95 Million |
| Other non-cash items | -42.69 Million | 5.38 Million | 5.38 Million | 107.79 Million | 7.72 Million | 848 Thousand |
| Investing Cash Flow | -63.08 Million | 80.29 Million | -94.54 Million | -99.21 Million | -150.64 Million | 25.92 Million |
| Investments in PPE | -28.4 Million | -69.48 Million | -31.15 Million | -22.68 Million | -41.02 Million | -10.28 Million |
| Acquisitions | -23.26 Million | 250 Thousand | - | - | - | - |
| Investment purchases | -23.26 Million | 10.05 Million | -10.05 Million | - | -70.28 Million | - |
| Sales/Maturities of investments | -10.69 Million | 49.65 Million | - | - | - | 23.08 Million |
| Other Investing Activities | -1.51 Million | 42.91 Million | -53.4 Million | -76.53 Million | -2.57 Million | 11.36 Million |
| Financing Cash Flow | 4.73 Million | -140.59 Million | -63.12 Million | -121.07 Million | 7.43 Million | -204.07 Million |
| Debt repayment | -159.49 Million | -59.78 Million | -41.13 Million | - | -632.25 Million | -141.09 Million |
| Dividends payments | -89.13 Million | - | - | -72.01 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -154.75 Million | -59.47 Million | -60 Thousand | -49.05 Million | -509.26 Million | -46.59 Million |
| Accounts receivables | 25.29 Million | -65.46 Million | - | 9.39 Million | - | - |
| Accounts payables | 22.52 Million | 12.23 Million | - | - | - | - |
| Inventory | -53.18 Million | -13.41 Million | -25.03 Million | -7.37 Million | -15.96 Million | 7.16 Million |
| Other working capital | 2.94 Million | 6.97 Million | - | 63.6 Million | - | - |
| Cash at beginning of period | 667.86 Million | 703.62 Million | 830.5 Million | 798.34 Million | 508.04 Million | 980.42 Million |
| Cash at end of period | 711.4 Million | 667.86 Million | 703.62 Million | 830.5 Million | 798.34 Million | 508.04 Million |
| Capital Expenditure | -28.4 Million | -69.48 Million | -31.15 Million | -22.68 Million | -41.02 Million | -10.28 Million |
| Effect of forex changes on cash | 19.08 Million | 1.06 Million | 1.63 Million | -15.92 Million | 16.4 Million | -1.43 Million |
| Net cash flow / Change in cash | 43.53 Million | -35.75 Million | -126.88 Million | 32.16 Million | 290.3 Million | -472.37 Million |
| Free Cash Flow | 54.4 Million | -46.01 Million | -2 Million | 245.69 Million | 43.56 Million | 29.44 Million |
CNLTL
AWI
MUX
TBLAW
GFF
MOIL